CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,604,000 | -75.4% | 13,568 | -76.9% | 0.00% | -100.0% |
| Q3 2020 | $6,523,000 | -0.7% | 58,695 | -8.7% | 0.00% | 0.0% |
| Q2 2020 | $6,567,000 | -25.3% | 64,270 | -21.1% | 0.00% | -33.3% |
| Q1 2020 | $8,788,000 | -33.9% | 81,416 | -28.7% | 0.00% | 0.0% |
| Q4 2019 | $13,287,000 | -71.2% | 114,175 | -71.6% | 0.00% | -81.2% |
| Q3 2019 | $46,061,000 | -4.8% | 402,392 | -20.7% | 0.02% | +166.7% |
| Q2 2019 | $48,372,000 | +206.5% | 507,598 | +193.5% | 0.01% | -14.3% |
| Q1 2019 | $15,780,000 | +61.4% | 172,922 | +34.3% | 0.01% | +75.0% |
| Q4 2018 | $9,775,000 | -59.4% | 128,765 | -57.2% | 0.00% | -50.0% |
| Q3 2018 | $24,050,000 | +64.4% | 300,620 | +104.1% | 0.01% | +33.3% |
| Q2 2018 | $14,632,000 | +47.2% | 147,302 | +20.0% | 0.01% | +50.0% |
| Q1 2018 | $9,943,000 | +18.4% | 122,753 | +15.1% | 0.00% | +33.3% |
| Q4 2017 | $8,400,000 | +57.5% | 106,642 | +84.5% | 0.00% | +50.0% |
| Q3 2017 | $5,333,000 | – | 57,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |